Videos

Heather Greenlee, ND, PhD, MPH, provides strategies to mitigate the increased risk of cardiovascular disease in women with breast cancer.   



Dr. Greenlee on Mitigating the Risk of Cardiovascular Disease in Breast Cancer 

Scott S. Tykodi, MD, PhD, provides background to the phase 2 KEYNOTE-427 trial with pembrolizumab in renal cell carcinoma.

Dr. Tykodi on the KEYNOTE-427 Trial With Pembrolizumab in RCC

Articles

William R. Gwin III, MD, discusses the ongoing trial examining this novel combination and provided insight into the next steps for this research.

Alpha-TEA and Concurrent Trastuzumab Under Exploration in Refractory HER2+ Breast Cancer

William R. Gwin III, MD, discusses the safety profile of alpha-tocopheryloxyacetic acid in combination with trastuzumab in recurrent HER2-positive metastatic breast cancer.

Dr. Gwin on the Safety of &#945;-TEA Plus Trastuzumab in Recurrent HER2+ Breast Cancer

Jerald P. Radich, MD, discusses measuring minimal residual disease (MRD) in hematologic malignancies.

Dr. Radich on Measuring MRD in Hematologic Malignancies

Celestia S. Higano, MD, FACP, discusses the state of immunotherapy in prostate cancer.

SCCA

Latest from SCCA

New content coming soon, please check back later.